Clincosm LogoSign in Get a demo

Social Media Use During COVID-19

Sponsor
Jean Liu (Other)
Overall Status
Completed
CT.gov ID
NCT04305574
Collaborator
(none)
1,145
Enrollment
1
Location
1.5
Actual Duration (Months)
774.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The investigators plan to conduct a cross-sectional survey to examine how social media use during COVID-19 relates to: (1) information management, (2) assessment of the situation, and (3) affect.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Use of social media during COVID-19

Study Design

Study Type:
Observational
Actual Enrollment :
1145 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Getting it Right: Towards Responsible Social Media Use During a Pandemic
Actual Study Start Date :
Mar 7, 2020
Actual Primary Completion Date :
Apr 21, 2020
Actual Study Completion Date :
Apr 21, 2020

Arms and Interventions

Arm Intervention/Treatment
Community sample

We plan to recruit a representative sample of the Singapore population.

Behavioral: Use of social media during COVID-19
Participants' self-reported use of an official WhatsApp channel to receive and share news about COVID-19
Other Names:
  • WhatsApp

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Depression, Anxiety and Stress Scale [Single measurement (upon study enrolment)]

      21-item validated scale assessing symptoms of depression, anxiety, and stress (DASS-21): Min score = 0, Max score = 21; higher score indicates a worse outcome

    Other Outcome Measures

    1. Assessment of COVID-19 situation [Single measurement (upon study enrolment)]

      3 items on fear of the situation, confidence the government can manage the situation, and assessed chance of being infected (each rated using 4-point scales: min = 1, max = 4; higher scores indicate increased confidence / likelihood / fear)

    2. Familiarity and trust in COVID-related rumours [Single measurement (upon study enrolment)]

      Participants' self-report of their familiarity (yes/no) and belief of specific (yes/no), and whether they shared these on social media (yes/no)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • At least 21 years

    • Has stayed in Singapore for at least 2 years

    Exclusion Criteria:

    • Below 21 years

    • Has stayed in Singapore for less than 2 years

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Yale-NUS College Singapore Singapore 138527

    Sponsors and Collaborators

    • Jean Liu

    Investigators

    • Principal Investigator: Jean Liu, PhD, Yale-NUS College

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jean Liu, Assistant Professor, Yale-NUS College
    ClinicalTrials.gov Identifier:
    NCT04305574
    Other Study ID Numbers:
    • 2020-CERC-001
    First Posted:
    Mar 12, 2020
    Last Update Posted:
    Jul 7, 2020
    Last Verified:
    Jul 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jean Liu, Assistant Professor, Yale-NUS College
    COVID-19
    Social media
    Communication
    Additional relevant MeSH terms:
    Coronavirus Infections
    Depression

    Study Results

    No Results Posted as of Jul 7, 2020